Gewählte Publikation:
Lackner, H; Urban, C; Kaulfersch, W; Slavc, I; Gamillscheg, A; Hauer, C.
Cyclosporin A in severe aplastic anemia in children
Padiatr Padol. 1989; 24(4): 313-320.
(- Case Report)
PubMed
- Führende Autor*innen der Med Uni Graz
-
Lackner Herwig
- Co-Autor*innen der Med Uni Graz
-
Gamillscheg Andreas
-
Hauer Almuthe
-
Urban Ernst-Christian
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Abstract:
- Severe aplastic anemia should be treated with bone marrow transplantation if possible. Various clinical and experimental data support the view that the major pathogenetic defect in SAA is a dysregulated cellular immune response which in turn has a negative effect upon hematopoiesis. Therefore a large percentage of patients react favorably to treatment with immunosuppressive agents as antithymocyte globulin and high-dose methylprednisolone. Data concerning the efficiency of Cyclosporine A treatment are limited until now. We present in this report our own experience with Cyclosporine A treatment in three children with severe aplastic anemia who lack a bone marrow donor. Included is also a review of the present therapeutic possibilities.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adolescent -
-
Anemia, Aplastic - drug therapy
-
Antilymphocyte Serum - administration and dosage
-
Cyclosporins - administration and dosage
-
Dose-Response Relationship, Drug - administration and dosage
-
Drug Therapy, Combination - administration and dosage
-
Erythrocyte Count - drug effects
-
Female - drug effects
-
Hemoglobinometry - drug effects
-
Humans - drug effects
-
Infant - drug effects
-
Male - drug effects
-
Methylprednisolone - administration and dosage
-
Pregnancy - administration and dosage
-
Pregnancy Complications, Hematologic - drug therapy
-
Reticulocytes - drug effects